Trials / Completed
CompletedNCT01111630
Study of Erythropoietin (EPO) Administration Schedule
Compare the Hemoglobin and Hematocrit Variability Between Once & Three Times Weekly Erythropoietin Therapy for the Anemia in Patients With Maintenance Dialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the hemoglobin and hematocrit variability between once and three times weekly erythropoietin therapy for the anemia in patients with maintenance dialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | recomon (Epoetin Beta) | administer once weekly |
| DRUG | recomon (Epoetin Beta) | administer three times weekly |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2013-10-01
- Completion
- 2014-01-01
- First posted
- 2010-04-27
- Last updated
- 2014-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01111630. Inclusion in this directory is not an endorsement.